Edward Nunes

Dr. Nunes is principal investigator of the Greater New York Node of the National Institute on Drug Abuse (NIDA) Clinical Trials Network as well as other NIDA-funded studies on behavioral and medication treatments for substance dependence and related psychiatric disorders. Interests and ongoing studies include treatments for cocaine dependence in general, heroin and other opioid dependence, for nicotine dependence in general, and for addicted patients with co-occurring psychiatric disorders including depression, and post-traumatic stress disorder.

Types of treatment under study include medication treatments (naltrexone, buprenorphine, mirtazapine) as well as behavioral and psychotherapeutic approaches and computer-delivered treatments. Dr. Nunes also studies the challenges involved in implementing evidence-based treatments for substance use disorders in real-world community-based treatments settings.

Dr. Nunes also serves on the American Board of Addiction Medicine, as Co-Chair of the Columbia/New York State Psychiatric Institute’s Institutional Review Board, and on the National Advisory Council on Drug Abuse.